Elevation Point Wealth Partners LLC Takes Position in HealthEquity, Inc. $HQY

Elevation Point Wealth Partners LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 6,525 shares of the company’s stock, valued at approximately $589,000.

Several other hedge funds have also added to or reduced their stakes in the company. Sivia Capital Partners LLC bought a new stake in shares of HealthEquity in the second quarter valued at about $306,000. Arrowstreet Capital Limited Partnership bought a new position in HealthEquity during the second quarter worth about $4,747,000. Marshall Wace LLP acquired a new stake in HealthEquity in the 2nd quarter worth about $5,483,000. Amundi raised its stake in HealthEquity by 9.3% in the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock worth $3,059,000 after purchasing an additional 2,574 shares in the last quarter. Finally, Jump Financial LLC bought a new stake in HealthEquity in the 2nd quarter valued at about $449,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on HQY. Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research report on Monday, June 1st. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Barrington Research reaffirmed an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. Finally, Royal Bank Of Canada upped their price objective on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 3rd. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $110.93.

Insider Buying and Selling

In other news, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock worth $1,651,280 in the last three months. 1.60% of the stock is owned by corporate insiders.

HealthEquity Trading Down 0.0%

Shares of HQY stock opened at $105.40 on Tuesday. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $107.62. The stock’s fifty day moving average price is $97.01 and its two-hundred day moving average price is $87.37. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The company has a market cap of $8.81 billion, a PE ratio of 39.48, a P/E/G ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.